# FDA 483 - Mark Fesler, M.D. - May 23, 2025

Source: https://www.globalkeysolutions.net/records/483/mark-fesler-md/4925c653-4fac-443d-a585-d3928db4ec78

> FDA 483 for Mark Fesler, M.D. on May 23, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Mark Fesler, M.D.
- Inspection Date: 2025-05-23
- Product Type: drugs
- Office Name: Kansas City District Office
- Summary: Saint Lukes Hospital in Chesterfield, MO, was cited for significant deficiencies in conducting clinical trials. Observations included failure to follow investigational plans, enrolling ineligible subjects, issues with investigational medical product dosing and vital sign collection, and critical failures in reporting both serious and non-serious adverse events to the sponsor. These issues indicate a lack of adherence to clinical trial protocols and regulatory requirements.

## Related Officers

- [Logan M. Jones](https://www.globalkeysolutions.net/people/logan-m-jones/286ab813-461a-4bfc-a732-bcd4f0d6e596)

Company: https://www.globalkeysolutions.net/companies/mark-fesler-md/b2513ebf-aeb1-46e8-b7b8-867ad3c31066

Office: https://www.globalkeysolutions.net/offices/kansas-city-district-office/cd397ab1-df4e-46f1-ab1c-0f6db9abcf79